RE:RE:New Press Release - Theratechnologies Submits Updated Tesamorelin F8 Formulation sBLA for FDA Review10 months to reply to a submission they thought was a walk in the park. It means they had to redo many of what was required. Anyways, at least they pushed it out before they fiscal year-end. They can check that off their strategic obejectives of the year and get a bonus payout.
Th108.........., partnership........accreditive bolt-on...........and CHINA!!
If this was the best news out of four, we're in deep trouble.